首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1391926

弗雷澤症候群市場：依測試類型、最終用戶、地區

Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: 2023年11月13日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

弗雷澤症候群市場規模預計將從 2023 年的 1.412 億美元增至 2030 年的 2.005 億美元，預測期內複合年成長率為 5.1%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	1.412 億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	5.10%	2030年市場規模預測	2.005 億美元

圖 1. 弗雷澤症候群的全球市場佔有率（%），按地區分類，2023 年

弗雷澤症候群（FS）是一種罕見的遺傳性疾病，影響腎臟和性發育。弗雷澤症候群的特徵是腎臟疾病進展為末期腎功能衰竭和性腺發育不全，導致女性沒有月經週期。

Prader 博士於 1964 年創造了「弗雷澤症候群」這個術語。弗雷澤症候群是由位於 11 號染色體短臂上的 WT1 基因突變引起的。該基因在胚胎發育過程中的腎臟和性腺發育中發揮重要作用。 WT1 基因突變擾亂正常的細胞過程，導致弗雷澤症候群的特徵。

弗雷澤症候群的發生率估計為十萬分之一的活產兒。它主要影響女性，但男性也有罕見病例報告。弗雷澤症候群的診斷是基於臨床特徵、基因檢測和腎臟組織的組織病理學檢查。

市場動態：

弗雷澤綜合症市場是由多種因素驅動的。首先，由於對遺傳性疾病認知的提高和先進診斷技術的可用性，弗雷澤症候群的診斷率正在增加。因此，對基因測試和篩檢的需求不斷增加，推動了市場成長。

其次，弗雷澤症候群的日益普及也促進了市場的擴張。對有效的腎臟替代療法和長期管理策略的需求創造了對創新治療方案的需求。

不過，弗雷澤症候群市場也面臨一定的抑制因素。醫療保健專業人員和公眾對這種罕見疾病的認知有限，可能會導致診斷不足和治療延遲。此外，基因檢測和專門治療的高昂費用給患者及其家人帶來了挑戰。

儘管有這些挑戰，弗雷澤症候群市場仍存在一些機會。標靶治療藥物和個人化醫療方法的開發有望改善弗雷澤症候群患者的預後。此外，研究機構、製藥公司和倡導團體之間的合作可以加速更好的診斷工具和治療方法的研究。

本研究的主要特點

本報告對全球弗雷澤症候群市場進行了詳細分析，包括以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球弗雷澤綜合症市場的主要企業。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球弗雷澤症候群市場的各種策略矩陣，促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 141.2 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.10%	2030 Value Projection:	US$ 200.5 Mn

Dr. Prader in 1964 coined the term Frasier syndrome. It is caused by mutations in the WT1 gene located on the short arm of chromosome 11. This gene plays a crucial role in the development of the kidneys and gonads during embryogenesis. Mutations in the WT1 gene disrupt normal cellular processes, leading to the characteristic features of Frasier syndrome.

The incidence of Frasier syndrome is estimated to be around 1 in 100,000 live births. It predominantly affects females, although rare cases have been reported in males as well. The diagnosis of Frasier syndrome is based on clinical features, genetic testing, and histopathological examination of kidney tissue.

Market Dynamics:

The market for Frasier syndrome is driven by several factors. Firstly, rising awareness about genetic disorders and the availability of advanced diagnostic techniques have led to an increased diagnosis rate of Frasier syndrome. This has resulted in a growing demand for genetic tests and screenings, driving market growth.

Secondly, the increasing prevalence of Frasier syndrome has also contributed to market expansion. The need for effective renal replacement therapies and long-term management strategies has created a demand for innovative treatment options.

However, the market for Frasier syndrome faces certain restraints as well. Limited awareness among healthcare professionals and the general public about this rare disorder can lead to underdiagnosis and delayed treatment. Moreover, the high cost of genetic testing and specialized treatments poses a challenge for patients and their families.

Despite these challenges, the market for Frasier syndrome presents several opportunities. The development of targeted therapies and personalized medicine approaches holds promise for improved outcomes in patients with Frasier syndrome. Furthermore, collaborations between research institutions, pharmaceutical companies, and advocacy groups can help drive research on better diagnostic tools and treatment modalities.

Key Features of the Study:

This report provides in-depth analysis of the global Frasier syndrome market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Frasier syndrome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Frasier syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Frasier syndrome market

Frasier Syndrome Market Segmentation:

By Test Type
- Genetic Testing
- Ultrasound Testing
- Others
By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Frasier Syndrome Market:
- Thermo Fisher Scientific
- Invitae Corporation
- GE Healthcare
- Koninklijke Philips N.V.
- Mindray Medical
- Siemens
- Canon Medical Systems Corporation
- FUJIFILM Sonosite Inc.
- ESAOTE SPA, SAMSUNGHEALTHCARE
- Empire Genomics Inc.
- BPL Medical Technologies
- Trivitron Healthcare
- Hitachi Healthcare

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Frasier Syndrome, By Test Type
- Market Frasier Syndrome, By End User
- Market Frasier Syndrome, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising awareness about genetic disorders
- Restraints
Limited awareness among healthcare professionals
- Opportunities
The development of targeted therapies and personalized medicine approaches
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Frasier Syndrome Market , By Test Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Ultrasound Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Frasier Syndrome Market , By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Frasier Syndrome Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Mn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mindray Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Sonosite Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
ESAOTE SPA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SAMSUNGHEALTHCARE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Empire Genomics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BPL Medical Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Trivitron Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views